Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Sir_John_Savill

Sir John Savill to head up MRC

August 11, 2010 Research and Development MRC, appointment, research and development

The Medical Research Council has appointed Sir John Savill as chief executive and deputy chair with effect from 1 October. …
Appointment

Medical Affairs at the centre of life sciences innovation

August 11, 2010 Research and Development Kinapse, Medical Affairs

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Feature

Elan halts separation plans

August 10, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elan

Irish drugmaker Elan has postponed plans to separate its business into two publicly-listed companies due to adverse market conditions. Elan …
News

ACM Global expands UK and US teams

August 10, 2010 Manufacturing and Production, Research and Development ACM Global, appointment, manufacturing and production, research and development

Clinical services company ACM Global has made several new appointments at its UK and US facilities. Its Global Central Laboratory …
Appointment

CMP Therapeutics appoints Dr Neill Moray Mackenzie

August 9, 2010 Research and Development CMP Therapeutics, appointment, research and development

Dr Neill Moray Mackenzie has joined Hertfordshire, UK-based biopharmaceutical company CMP Therapeutics as chief executive. He has a long record …
Appointment

Doctors reach online tipping point: is pharma ready to respond?

August 5, 2010 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMA, Doctors.net.uk, GMC, GPs, Lansley, doctors, medeconnect, professional network

 This article was originally published by PharmaPhorum in Spring 2010.  
Feature
Thought Leadership

Daiichi’s lung cancer drug progresses to phase III

August 5, 2010 Research and Development Daiichi, arq 197, arqule, lung cancer, phase III

Daiichi Sankyo and biotech firm Arqule are to move their lung cancer treatment ARQ 197 into phase III trials. The …
News
Kevin-Gordon-Quintiles-CFO

Quintiles appoints Kevin Gordon finance chief

August 5, 2010 Research and Development Quintiles, appointment, research and development

Pharmaceutical services company Quintiles has named Kevin Gordon chief financial officer. He will have day-to-day responsibility for the company’s financial …
Appointment

Shire moves in on Movetis

August 5, 2010 Research and Development, Sales and Marketing Movetis, Shire

Shire has made a €428 million offer for Belgium-based Movetis in a bid to grow its business in Europe and …
News

Charles River calls a halt to WuXi merger plans

August 4, 2010 Research and Development Charles River Laboratories, WuXi

Charles River Laboratories has terminated its $1.6 billion agreement to acquire Chinese contract research organisation WuXi PharmaTech after an investor …
News

Cegedim appoints Anne-Marie Masquelier

August 4, 2010 Research and Development Cegedim, appointment, research and development

Anne-Marie Masquelier has joined healthcare research company Cegedim Strategic Data as global medical research director. She will be responsible for …
Appointment

EDC: Looking beyond the software

August 4, 2010 Research and Development EDC, chiltern

Electronic data capture (EDC) has become the norm for clinical studies. In an EDC study, most of the deliverables are …
Feature

Sanofi appoints Dr Ian Weatherhead UK coms director

August 4, 2010 Medical Communications, Research and Development, Sales and Marketing Sanofi-Aventis, UK, appointment, research and development, sales and marketing

Sanofi-Aventis UK has appointed Dr Ian Weatherhead as its director of communications. Ian will join the Guildford-based company in October, …
Appointment

Dr Wolfgang Renz joins PharmaNet

August 3, 2010 Manufacturing and Production, Research and Development PharmaNet, appointment, manufacturing and production, research and development

PharmaNet Development Group has appointed Dr Wolfgang Renz senior vice president of clinical operations. He will be responsible for the …
Appointment

Roche appoints Karen Lackey head of medicinal chemistry

August 3, 2010 Manufacturing and Production, Research and Development Roche, appointment, manufacturing and production, research and development

Karen Lackey has been appointed vice-president and head of medicinal chemistry by Roche. She will be based at the company’s …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026